Antipodes Partners’s MYR Group MYRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.5K Sell
97
-214
-69% -$87.9K ﹤0.01% 114
2026
Q1
$87.8K Hold
311
﹤0.01% 95
2025
Q4
$68K Buy
311
+10
+3% +$2.18K ﹤0.01% 100
2025
Q3
$62.6K Sell
301
-403
-57% -$75.2K ﹤0.01% 92
2025
Q2
$128K Sell
704
-15
-2% -$2.2K ﹤0.01% 68
2025
Q1
$81.3K Buy
719
+101
+16% +$13.4K ﹤0.01% 76
2024
Q4
$91.9K Buy
618
+72
+13% +$10.1K ﹤0.01% 63
2024
Q3
$55.8K Buy
546
+451
+475% +$51.2K ﹤0.01% 69
2024
Q2
$12.9K Buy
+95
New +$14.8K ﹤0.01% 76

Other funds holding MYRG

Antipodes Partners's MYRG Position: Q2 2026 in Review

Antipodes Partners reduced its MYR Group (MYRG) stake by 69% in Q2 2026, selling an estimated $87.9K and leaving 97 shares worth $48.5K. The position accounts for ﹤0.01% of the portfolio, ranked #114.

Antipodes Partners first reported a position in MYRG in Q2 2024 and has held it in 9 quarters since. The position peaked at $128K in Q2 2025. 217 funds tracked by Wall St. Rank hold MYRG as of Q2 2026.

  • Antipodes Partners held 97 shares of MYR Group worth $48.5K as of Q2 2026.
  • Antipodes Partners sold 214 MYR Group shares in Q2 2026, an estimated $87.9K.
  • MYR Group made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #114 holding.
  • Antipodes Partners first reported a position in MYR Group in Q2 2024 and has held it in 9 quarters since.
  • Antipodes Partners's MYR Group position peaked at $128K in Q2 2025.
  • 217 funds tracked by Wall St. Rank held MYR Group as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.